: Systemic vasculitides comprise a collection of rare and heterogeneous disorders capable of impacting any organ and system, posing a considerable burden of mortality and comorbidity. As with previous annual reviews of this series, this review will offer a critical overview of the latest literature on pathogenesis, biomarkers, and treatment options in both small- and large-vessel vasculitis.
Systemic vasculitis: one year in review 2024 / Treppo, E.; Monti, S.; Delvino, P.; Marvisi, C.; Ricordi, C.; La Rocca, G.; Moretti, M.; Italiano, N.; Cianni, F. D.; Ferro, F.; Muratore, F.; Baldini, C.; Talarico, R.; Quartuccio, L.; Salvarani, C.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 42:4(2024), pp. 771-781. [10.55563/clinexprheumatol/gkve60]
Systemic vasculitis: one year in review 2024
Marvisi C.;Ricordi C.;Muratore F.;Salvarani C.
2024
Abstract
: Systemic vasculitides comprise a collection of rare and heterogeneous disorders capable of impacting any organ and system, posing a considerable burden of mortality and comorbidity. As with previous annual reviews of this series, this review will offer a critical overview of the latest literature on pathogenesis, biomarkers, and treatment options in both small- and large-vessel vasculitis.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris